Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

詳細情報 詳細情報について

• CRID

  1360855569401606016

• DOI

  10.1016/s1470-2045(09)70025-7

• ISSN

  14702045

  http://id.crossref.org/issn/14702045

• Web Site

  https://api.elsevier.com/content/article/PII:S1470204509700257?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1470204509700257?httpAccept=text/plain

• データソース種別

  • Crossref